Preferred Label : treatment failure;

MeSH definition : A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.;

MeSH synonym : treatment failures; failure, treatment; failures, treatment;

Wikipedia automatic translation : Tachyphylaxis;

MeSH annotation : IM: GEN only; coord NIM with dis /ther (IM), as analysis of treatment failure in AIDS or with specific ther or intervention (IM); coordinate with disease /ther, as analysis of treatment failure in AIDS or with specific therapy or intervention;

Wikipedia link : https://en.wikipedia.org/wiki/Tachyphylaxis;

Details


Main resources

You can consult :

A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.

https://dumas.ccsd.cnrs.fr/dumas-04550093
2024
France
dissertations, academic
Over the Counter Product
Under No Medication
Pharmacologic Substance
classification
Version
prescription of drug, nos
Treatment
Therapeutic
play and playthings
play
treatment failure
Therapeutic Procedure
anthelmintics
What Month is it
Failure
Review
Systematic Review
drug prescriptions

---
https://www.has-sante.fr/jcms/p_3545707/fr/adaptation-du-traitement-antiretroviral-en-situation-d-echec-virologique-chez-l-adulte-vivant-avec-le-vih
2024
France
practice guideline
rehabilitation
adult
habilitation
anti-retroviral agents
human immunodeficiency virus, nos
HIV
treatment failure
adulthood
virology
adaptation, nos

---
https://www.inspq.qc.ca/publications/3331
2023
Canada
technical report
Gonococcal infection
treatment failure
drug resistance, microbial
gonorrhea
reticulum
quebec
resulting in
sentinel surveillance
gonorrhea, nos

---
https://www.inspq.qc.ca/publications/3330
2023
Canada
technical report
reticulum
quebec
drug resistance, microbial
treatment failure
Gonococcal infection
gonorrhea, nos
gonorrhea
sentinel surveillance
resulting in

---
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
https://recalls-rappels.canada.ca/fr/avis-rappel/sotrovimab-pour-injection-risque-echec-therapeutique-en-raison-circulation-du-ba2-sous
2022
false
false
false
Canada
French
English
COVID-19
risk
pharmacovigilance note
treatment failure
sotrovimab
SARS-CoV-2 variants
new coronavirus variant
infusions, intravenous
sotrovimab

---
https://recalls-rappels.canada.ca/fr/avis-rappel/casirivimab-et-imdevimab-risque-eleve-echec-therapeutique-en-raison-circulation-du
2022
false
false
false
Canada
French
English
pharmacovigilance note
COVID-19
casirivimab and imdevimab drug combination
risk
drug combinations
imdevimab
casirivimab
treatment failure
canada
SARS-CoV-2 variants

---
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75503a-fra.php
2021
false
false
false
Canada
French
pharmacovigilance note
antibodies, monoclonal, humanized
antiviral agents
risk
treatment failure
new coronavirus variant
drug resistance, viral
adult
adolescent
bamlanivimab
SARS-CoV-2
COVID-19

---
https://ansm.sante.fr/informations-de-securite/genvoya-r-stribild-r-risque-accru-dechec-virologique-et-secondairement-de-transmission-de-linfection-vih-de-la-mere-a-lenfant
2019
false
false
false
France
French
infectious disease transmission, vertical
treatment failure
hiv infections
pregnancy trimester, second
pregnancy trimester, third
hiv infections
pharmacovigilance note
anti-hiv agents
elvitegravir
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
guidelines for drug use
risk
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
pregnancy
infant, newborn
elvitegravir
Emtricitabine
Tenofovir
Cobicistat
drug combinations
quinolones
quinolones

---
https://dumas.ccsd.cnrs.fr/dumas-01689411
2017
false
true
false
France
French
dissertations, academic
treatment failure
risk factors
abortion, induced

---
http://www.fmcgastro.org/postu-main/postu-2013-paris/textes-postu-2013-paris/ileite-terminale-refractaire
2013
false
true
false
false
France
treatment failure
crohn disease
anti-TNF
ileitis
teaching material
crohn disease

---
http://www.fmcgastro.org/postu-main/archives/postu-2011-paris/textes-postu-2011-paris/maladie-de-crohn-que-faire-quand-tout-a-echoue/
2011
false
true
false
false
France
teaching material
crohn disease
treatment failure
crohn disease
crohn disease
crohn disease

---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/044000467.pdf
2004
France
French
Therapy cessation
skin biopsy
acquired immunodeficiency syndrome
hiv infections
france
acquired immunodeficiency syndrome
hiv infections
population surveillance
mass screening
hiv infections
acquired immunodeficiency syndrome
hiv infections
acquired immunodeficiency syndrome
anti-hiv agents
anti-hiv agents
patient selection
antiretroviral therapy, highly active
antiretroviral therapy, highly active
risk factors
patient education as topic
anti-hiv agents
continuity of patient care
treatment outcome
medical history taking
physical examination
hiv infections
acquired immunodeficiency syndrome
hiv infections
acquired immunodeficiency syndrome
communication
treatment failure
hiv infections
acquired immunodeficiency syndrome
drug resistance, viral
microbial sensitivity tests
predictive value of tests
microbial sensitivity tests
microbial sensitivity tests
anti-hiv agents
dose-response relationship, drug
anti-hiv agents
drug interactions
anti-hiv agents
quality control
hiv-associated lipodystrophy syndrome
hiv-associated lipodystrophy syndrome
hiv-associated lipodystrophy syndrome
hiv-associated lipodystrophy syndrome
Plastic Surgery Procedures
glucose intolerance
hyperinsulinism
diabetes mellitus
glucose intolerance
diabetes mellitus
hyperinsulinism
glucose intolerance
diabetes mellitus
hyperinsulinism
glucose intolerance
hyperinsulinism
diabetes mellitus
hypertriglyceridemia
hypercholesterolemia
hypertriglyceridemia
hypercholesterolemia
hypertriglyceridemia
hypercholesterolemia
hypercholesterolemia
hypertriglyceridemia
cardiovascular diseases
bone diseases
osteoporosis
bone diseases
osteoporosis
osteonecrosis
acidosis, lactic
mitochondrial diseases
immunotherapy
Interleukin-2
Interleukin-2
aids-related opportunistic infections
hepatitis C
hepatitis C
hepatitis C
ribavirin
ribavirin
interferons
interferons
hepatitis B
hepatitis B
hepatitis B
hepatitis A
hepatitis, chronic
liver cirrhosis
aids-related opportunistic infections
biopsy, needle
cause of death
pneumonia, pneumocystis
toxoplasmosis, cerebral
chemoprevention
tuberculosis
cryptococcosis
cytomegalovirus infections
antibiotic prophylaxis
candidiasis
leishmaniasis, visceral
intestinal diseases, parasitic
hiv infections
acquired immunodeficiency syndrome
mycobacterium infections
herpesvirus 8, human
herpes simplex
health services accessibility
transients and migrants
patient rights
poverty
socioeconomic factors
housing
insurance
prisons
prisoners
hospitalization
patient care
Long-Term care
herpesviridae infections
uterine cervical neoplasms
anus neoplasms
hodgkin disease
vaccination
vaccination
pneumococcal vaccines
meningococcal vaccines
haemophilus vaccines
hepatitis B vaccines
hepatitis A vaccines
BCG vaccine
yellow fever vaccine
signs and symptoms
HIV-2
pregnancy
risk assessment
prenatal diagnosis
infectious disease transmission, vertical
child
pregnancy complications
adolescent
infant, newborn
infant, newborn, diseases
hiv infections
acquired immunodeficiency syndrome
women
reproductive techniques, assisted
contraception
sexuality
sexual behavior
sexually transmitted diseases
sexual dysfunction, physiological
martinique
guadeloupe
french guiana
pregnancy, multiple
Contraindications, Procedure
Contraindications, Drug
HIV seropositivity
lymphoma, Non-Hodgkin
medication adherence
coinfection
practice guideline

---
Nous contacter.
01/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.